October 3, 2017

The UBS Oncology Impact Fund Co-leads $150 Million Series A Financing of Cullinan Oncology

Cullinan Oncology is an Innovative Development Company with an Accomplished Management Team to Develop Pipeline of Novel Cancer Therapies